𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Review: Perioperative therapy for locoregional nonsmall-cell lung cancer

✍ Scribed by Takita, Hiroshi

Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
929 KB
Volume
62
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

✦ Synopsis

Surgical therapy remains the treatment of choice for resectable nonsmallcell lung cancer (NSCLC). However, the 5-year survival results of surgical therapy is 40-70%, which is far from acceptable. In this report, past results of perioperative therapies were reviewed to identify the future direction of effort in improving the therapy of NSCLC. Two perioperative modes of treatment that may possibly improve postsurgical survival were identified, i.e., neoadjuvant chemotherapy for resectable NSCLC and postoperative specific active immunotherapy. 0 1996 WiIey-Liss, Inc.

πŸ“œ SIMILAR VOLUMES

High-dose proton therapy and carbon-ion
High-dose proton therapy and carbon-ion therapy for stage I nonsmall cell lung cancer
✍ Hiromitsu Iwata; Masao Murakami; Yusuke Demizu; Daisuke Miyawaki; Kazuki Terashi πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 318 KB πŸ‘ 1 views

## Abstract ## BACKGROUND: A study was undertaken to evaluate the clinical outcome of particle therapy for stage I nonsmall cell lung cancer (NSCLC). ## METHODS: From April 2003 to April 2007, 80 patients with stage I NSCLC were treated with proton therapy or carbon‐ion therapy (57 with proton t

Long-term outcome after pneumonectomy fo
Long-term outcome after pneumonectomy for nonsmall cell lung cancer
✍ Rocco, Patrick M.; Antkowiak, Joseph G.; Takita, Hiroshi; Urschel, John D. πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 236 KB πŸ‘ 2 views

Long-term survivors (5 or more years) of pneumonectomy for nonsmall cell lung cancer are at risk for late death from cancer recurrence, second primary malignancies, and cardiopulmonary insufficiency related to the adverse physiological effects of pneumonectomy. A retrospective study of pneumonectomy

Temporal trends and predictors of periop
Temporal trends and predictors of perioperative chemotherapy use in elderly patients with resected nonsmall cell lung cancer
✍ Jue Wang; Yong Fang Kuo; Jean Freeman; Avi B. Markowitz; James S. Goodwin πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 245 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. The authors assessed patterns of perioperative chemotherapy use in elderly patients with resected stage I, II, or IIIA nonsmall cell lung cancer (NSCLC) from 1992 to 2002. ## METHODS. By using data from the Surveillance, Epidemiology, and End Results Program, 11,807 pa